Published in J Immunol on January 01, 1984
B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. EMBO J (1988) 2.88
B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med (1988) 2.64
Lineage specification and plasticity in CD19- early B cell precursors. J Exp Med (2006) 1.80
Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors. Proc Natl Acad Sci U S A (1985) 1.75
Isolation of a cDNA copy of an RNA species expressed in murine pre-B cells. EMBO J (1986) 1.63
Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity (2007) 1.50
Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny. J Exp Med (1995) 1.20
Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. Proc Natl Acad Sci U S A (1993) 1.19
CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proc Natl Acad Sci U S A (2009) 1.04
In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded > 100-fold by coculture with a clonal yolk sac endothelial cell line. Proc Natl Acad Sci U S A (1996) 1.03
TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses. PLoS One (2009) 0.96
Establishment and characterization of lymphoid and myeloid mixed-cell populations from mouse late embryoid bodies, "embryonic-stem-cell fetuses". Proc Natl Acad Sci U S A (1992) 0.95
Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells. Proc Natl Acad Sci U S A (1997) 0.93
A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state. Immunogenetics (2010) 0.85
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies. Oncoimmunology (2014) 0.79
Identification of a unique membrane-bound molecule on a hemopoietic stem cell line and on multipotent progenitor cells. Proc Natl Acad Sci U S A (1995) 0.77
Purification, Visualization, and Molecular Signature of Neural Stem Cells. Stem Cells Dev (2015) 0.77
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell (1989) 6.66
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol (1990) 5.26
Subclass restriction of murine anti-carbohydrate antibodies. J Immunol (1978) 4.99
Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A (1984) 3.14
Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med (1980) 3.13
Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs. J Exp Med (1971) 2.92
Effect of teichoic acid on resistance to the membrane-lytic agent of Streptococcus zymogenes. J Bacteriol (1966) 2.87
Cellular and developmental properties of fetal hematopoietic stem cells. Cell (1990) 2.83
Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol (1990) 2.25
Depletion of antibody-forming cells and their precursors from complex lymphoid cell populations. J Immunol (1972) 2.24
Foamy virus particle formation. J Virol (1998) 2.22
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis (1979) 2.15
Syrinx 2A: an improved lambda phage vector designed for screening DNA libraries by recombination in vivo. Proc Natl Acad Sci U S A (1987) 2.11
Receptors on immunocompetent cells. 3. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding cells of immunized guinea pigs. J Exp Med (1971) 2.11
Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response. J Exp Med (1972) 2.03
Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies. J Exp Med (1974) 2.02
Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies. J Immunol (1974) 1.95
Amino acid sequence of homogeneous antibodies to dextran and DNA rearrangements in heavy chain V-region gene segments. Nature (1980) 1.94
Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med (1974) 1.85
Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science (1979) 1.82
Interleukin-3 supports growth of mouse pre-B-cell clones in vitro. Nature (1984) 1.76
Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors. Proc Natl Acad Sci U S A (1985) 1.75
Action of streptolysin S, the group D hemolysin, and phospholipase C on whole cells and spheroplasts. J Bacteriol (1966) 1.72
Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther (2000) 1.71
Receptors on immunocompetent cells. I. Receptor specificity of cells participating in a cellular immune response. Cell Immunol (1970) 1.70
Coronary disease severity and functional impairment: how strong is the relation? J Am Geriatr Soc (1996) 1.66
Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Arch Intern Med (1991) 1.62
Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med (1979) 1.54
L2C Guinea pig lymphatic leukemia: a "B" cell leukemia. Blood (1972) 1.52
Cross-reactions of the group-specific polysaccharides of streptococcal groups B and G in anti-pneumococcal sera with especial reference to type 23 and its determinants. J Immunol (1967) 1.51
Electrophoretic analysis of polypeptide chains isolated from antibodies in the serum of immunized rabbits. J Immunol (1967) 1.51
Design of 5' untranslated sequences in retroviral vectors developed for medical use. J Virol (1999) 1.48
Structural correlates of cross-reactive and individual idiotypic determinants on murine antibodies to alpha-(1 leads to 3) dextran. J Exp Med (1980) 1.46
Role of T lymphocytes in the humoral immune response. I. Proliferation of B lymphocytes in thymus-deprived mice. J Immunol (1974) 1.46
Membrane-associated immunoglobulin of rabbit peripheral blood lymphocytes: allelic exclusion at the b locus. Proc Natl Acad Sci U S A (1971) 1.45
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther (2006) 1.44
Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol (1985) 1.42
Trends in use of oral hypoglycemic agents 1964-1986. Diabetes Care (1989) 1.42
Long-term effects of otitis media: a ten-year cohort study of Alaskan Eskimo children. Pediatrics (1973) 1.40
Phage display mutagenesis of the chimeric dual cytokine receptor agonist myelopoietin. Leukemia (2001) 1.40
Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther (2006) 1.39
The validity of Medicaid diagnoses of hip fracture. Am J Public Health (1993) 1.38
Receptors on immunocompetent cells. IV. Direct measurement of avidity of cell receptors and cooperative binding of multivalent ligands. J Exp Med (1972) 1.38
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia (2008) 1.35
Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J Exp Med (1980) 1.34
Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum (1985) 1.32
Hapten-specific tolerance. Preferential depression of the high affinity antibody response. J Exp Med (1972) 1.31
Mapping cell surface antigens on mouse pre-B cell lines. Eur J Immunol (1985) 1.29
Immunoglobulin lambda light-chain-related genes 14.1 and 16.1 are expressed in pre-B cells and may encode the human immunoglobulin omega light-chain protein. Proc Natl Acad Sci U S A (1989) 1.29
Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. Am J Med (1997) 1.27
B cell subsets and differential responses to mitogens. Immunol Rev (1982) 1.26
Isoelectric focusing of immunoglobulins: improved methodology. J Immunol Methods (1980) 1.26
Synthetic idiotypes: the third hypervariable region of murine anti-dextran antibodies. Cell (1983) 1.26
Multiple VH gene segments encode murine antistreptococcal antibodies. J Exp Med (1984) 1.26
Clonal dominance. I. Restricted nature of the IgM antibody response to group A streptococcal carbohydrate in mice. J Exp Med (1975) 1.24
Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health (1988) 1.24
Immune cryoglobulins in rabbit streptococcal antiserum. J Immunol (1968) 1.24
Pois(s)on--it's a question of dose... Gene Ther (2004) 1.23
Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens. J Exp Med (1980) 1.23
Self-inactivating retroviral vectors with improved RNA processing. Gene Ther (2004) 1.23
Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidable. Semin Hematol (2004) 1.22
Induction of rejection of successful allografts of rat islets by donor peritoneal exudate cells. Transplantation (1979) 1.22
Clonal nature of the immune response to phosphorylcholine (PC). V. Cross-idiotypic specificity among heavy chains of murine anti-PC antibodies and PC-binding myeloma proteins. J Exp Med (1975) 1.20
Drug use in the United States in 1981. JAMA (1984) 1.18
Prolongation of islet xenograft survival without continuous immunosuppression. Science (1980) 1.18
Differentiation of murine B cell precursors in agar culture. Frequency, surface marker analysis and requirements for growth of clonable pre-B cells. Eur J Immunol (1984) 1.18
A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc Natl Acad Sci U S A (1999) 1.16
Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells. J Exp Med (1991) 1.16
Deletion of b5 immunoglobulin-bearing lymphocytes in allotype-suppressed rabbits. J Exp Med (1973) 1.16
Detection of isoelectric focused antibody by autoradiography and hemolysis of antigen-coated erythrocytes. A comparison of methods. J Immunol Methods (1975) 1.16
Monoclonal antibodies to streptococcal group A carbohydrate. I. A dominant idiotypic determinant is located on Vk. J Immunol (1982) 1.15
The impact of the addition of naloxone on the use and abuse of pentazocine. Public Health Rep (1987) 1.13
Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology (2007) 1.11
Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther (2008) 1.11
Antigen-binding receptors on lymphocytes. Contemp Top Immunobiol (1974) 1.10
CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol Ther (2000) 1.10
Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci U S A (1987) 1.10
Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest (1985) 1.10
Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus-dependent antigens. Eur J Immunol (1979) 1.10
Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells. Gene Ther (2001) 1.08
Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Ther (2001) 1.07
Specific isolation and characterization of antibody directed to binding site antigenic determinants. J Immunol (1975) 1.06
Complete sharing of light chain spectrotypes by murine IgM and IgG anti-streptococcal antibodies. J Immunol (1977) 1.05
Analysis of the diversity of murine antibodies to dextran B1355. III. Idiotypic and spectrotypic correlations. Eur J Immunol (1978) 1.05
Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol (1999) 1.05
Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency. J Exp Med (1983) 1.04
Streptococcal group A carbohydrate has properties of both a thymus-independent (TI-2) and a thymus-dependent antigen. J Immunol (1982) 1.04
Isotretinoin and pregnancy. J Am Acad Dermatol (1984) 1.03
Active suppression in the maintenance of pancreatic islet allografts. Transplantation (1981) 1.01
Molecular dissection of the murine antibody response to streptococcal group A carbohydrate. J Exp Med (1987) 1.01
A novel NK-related mouse homeobox gene: expression in central and peripheral nervous structures during embryonic development. Dev Biol (1994) 1.01
Immune response to liposomal model membranes: restricted IgM and IgG anti-dinitrophenyl antibodies produced in guinea pigs. J Immunol (1975) 1.00
Transplantation of insulin-producing tissue. Am J Med (1981) 1.00
Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype. J Exp Med (1975) 0.99
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA. Leukemia (2007) 0.99